Francisco Baralle

Affiliations: 
University of Oxford, Oxford, United Kingdom 
Google:
"Francisco Baralle"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Skoko N, Baralle M, Baralle FE. (2015) Absence of TDP-43 is difficult to digest. The Embo Journal
Cragnaz L, Klima R, De Conti L, et al. (2015) An age-related reduction of brain TBPH/TDP-43 levels precedes the onset of locomotion defects in a Drosophila ALS model. Neuroscience
Colombrita C, Onesto E, Buratti E, et al. (2015) From transcriptomic to protein level changes in TDP-43 and FUS loss-of-function cell models. Biochimica Et Biophysica Acta. 1849: 1398-1410
Romano G, Appocher C, Scorzeto M, et al. (2015) Glial TDP-43 regulates axon wrapping, GluRIIA clustering and fly motility by autonomous and non-autonomous mechanisms. Human Molecular Genetics. 24: 6134-45
Mompeán M, Hervás R, Xu Y, et al. (2015) Structural Evidence of Amyloid Fibril Formation in the Putative Aggregation Domain of TDP-43. The Journal of Physical Chemistry Letters. 6: 2608-15
Romano V, Quadri Z, Baralle FE, et al. (2015) The structural integrity of TDP-43 N-terminus is required for efficient aggregate entrapment and consequent loss of protein function. Prion. 9: 1-9
Budini M, Romano V, Quadri Z, et al. (2015) TDP-43 loss of cellular function through aggregation requires additional structural determinants beyond its C-terminal Q/N prion-like domain. Human Molecular Genetics. 24: 9-20
Romano G, Klima R, Buratti E, et al. (2014) Chronological requirements of TDP-43 function in synaptic organization and locomotive control. Neurobiology of Disease. 71: 95-109
Cragnaz L, Klima R, Skoko N, et al. (2014) Aggregate formation prevents dTDP-43 neurotoxicity in the Drosophila melanogaster eye. Neurobiology of Disease. 71: 74-80
Budini M, Baralle FE, Buratti E. (2014) Targeting TDP-43 in neurodegenerative diseases. Expert Opinion On Therapeutic Targets. 18: 617-32
See more...